Company identity
Company number 04140420
Company profile
UK company 04140420, incorporated on 12 January 2001.
5D Health Protection Group Ltd - Centre of Excellence in Biofilm Science and Infection Control
5Dhpg is a globally leading independent and innovative contract scientific testing and research focused organisation with over 28 years of experience based in Liverpool, Merseyside
Company number 04140420
Updated 07 Jul 2026 09:49
Financial period: 1 Apr 2024 to 31 Mar 2025
Reference milestones and recent Companies House filing stream events.
Next accounts due date
Next confirmation statement due date
CS01 | Transaction MzUzNzk4NTEzOGFkaXF6a2N4
Published 11 Aug 2026 15:45
Last confirmation statement made up date
Last accounts made up date
Company registered at Companies House
1 Oct 2018 to 30 Sep 2021
This project is a collaboration between NanoFlex Ltd and the 5D Health Protection Group Ltd. The research and development collaboration will develop and prove the feasibility and relevance of the sensor data generated in the context of managing wounds. It is believed that with the appropriate information of those suffering from chronic wounds individuals ...
1 Mar 2018 to 28 Feb 2021
This project is a collaboration between the 5D Health Protection Group Ltd and the University of Bradford. The research and development collaboration will enable the development of state-of-the-art bioresponsive polymeric nanotherapeutic molecules which respond to changes in the wound environment, linked to elevated matrix metalloproteinases (MMPs) levels...
1 Mar 2016 to 28 Feb 2017
This project is a collaboration between the 5D Health Protection Group Ltd and the University of Liverpool Clinical Engineering Department. The research and development collaboration will enable the development of the next generation antibiofilm technologies that can be applied to medical platforms for enhancing clinical outcome. One important area for us...
1 May 2015 to 31 Oct 2015
To project aims to investigate the development of a new anti-biofilm framework to reduce microbial attachment and biofilm formation on materials used in the healthcare industry but in particular, woundcare. The framework would be applied topically in liquids, gels, wound dressings and other medical devices to accelerate wound healing and prevent or treati...